PEG-nanolized ultrasmall selenium nanoparticles overcome drug resistance in hepatocellular carcinoma HepG2 cells through induction of mitochondria dysfunction.
about
Friend or foe? The current epidemiologic evidence on selenium and human cancer riskNovel walnut peptide-selenium hybrids with enhanced anticancer synergism: facile synthesis and mechanistic investigation of anticancer activityCharacterization and Potential Applications of a Selenium Nanoparticle Producing and Nitrate Reducing Bacterium Bacillus oryziterrae sp. novOxoaporphine Metal Complexes (CoII, NiII, ZnII) with High Antitumor Activity by Inducing Mitochondria-Mediated Apoptosis and S-phase Arrest in HepG2.Novel Functionalized Selenium Nanoparticles for Enhanced Anti-Hepatocarcinoma Activity In vitro.Biofunctionalization of Selenium Nanoparticle with Dictyophora Indusiata Polysaccharide and Its Antiproliferative Activity through Death-Receptor and Mitochondria-Mediated Apoptotic Pathways.Multifunctional selenium nanoparticles as carriers of HSP70 siRNA to induce apoptosis of HepG2 cells.The effect of red-allotrope selenium nanoparticles on head and neck squamous cell viability and growth.Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite.Combination of fenretinide and selenite inhibits proliferation and induces apoptosis in ovarian cancer cells.Antioxidant capacities of the selenium nanoparticles stabilized by chitosan.Transferrin-functionalized nanographene oxide for delivery of platinum complexes to enhance cancer-cell selectivity and apoptosis-inducing efficacy.Facile total synthesis of lysicamine and the anticancer activities of the RuII, RhIII, MnII and ZnII complexes of lysicamineTargeting nanomaterials: future drugs for cancer chemotherapy.A Summary of New Findings on the Biological Effects of Selenium in Selected Animal Species-A Critical Review.
P2860
Q27015669-231567C7-FA91-47B1-8C16-BF22D1EA3A93Q28392805-8D6743CD-EF7C-4BBA-9816-BB80DA04C427Q28828710-1EC8E617-70AD-4836-B045-0CBECFD0BACAQ33594393-17C2ADC7-2A3D-4EB9-8B90-09B57FA8B41AQ36023716-81C32C72-D877-4C79-B76E-A4FC3CCACCF9Q36388909-60BB76DB-DC16-4785-A019-5405D0EFFF60Q37082794-F803E1E8-F4DD-4165-9150-B63F9AF32C26Q37154978-2905B1F7-A284-4344-AD4C-F29A1D2CD248Q37164902-5B296CCB-D630-41CB-B3A9-A52E3396FB37Q37375377-D8CE70E8-C217-4C93-BB08-5A23C2B10E01Q37566587-FC759754-F63F-43D7-97D3-54B3611D9B8CQ38648996-DC922F0D-91D9-4FC4-A8D2-CB4AF9566006Q41708811-FA8DE9A8-65F0-4A4F-9032-32D1ABF37C8CQ42417118-489604C5-7305-4BA4-938E-A6E515661A7EQ44481320-342071F9-C681-4E94-94AD-1AD423AE2FCE
P2860
PEG-nanolized ultrasmall selenium nanoparticles overcome drug resistance in hepatocellular carcinoma HepG2 cells through induction of mitochondria dysfunction.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
PEG-nanolized ultrasmall selen ...... n of mitochondria dysfunction.
@ast
PEG-nanolized ultrasmall selen ...... n of mitochondria dysfunction.
@en
type
label
PEG-nanolized ultrasmall selen ...... n of mitochondria dysfunction.
@ast
PEG-nanolized ultrasmall selen ...... n of mitochondria dysfunction.
@en
prefLabel
PEG-nanolized ultrasmall selen ...... n of mitochondria dysfunction.
@ast
PEG-nanolized ultrasmall selen ...... n of mitochondria dysfunction.
@en
P2093
P2860
P356
P1476
PEG-nanolized ultrasmall selen ...... n of mitochondria dysfunction.
@en
P2093
Shanyuan Zheng
Tianfeng Chen
Wenjie Zheng
Xiaoling Li
Yibo Zhang
Yum-Shing Wong
P2860
P304
P356
10.2147/IJN.S30940
P407
P577
2012-07-23T00:00:00Z